PubRank

POWS: Palonosetron/Ondansetron Opioid Withdrawal Study

Clinical Trial ID NCT00661674

PubWeight™ 1.09‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00661674

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 1991 3.73
2 Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 1987 3.54
3 Opioid epidemic in the United States. Pain Physician 2012 3.40
4 Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA 2007 3.13
5 One night of total sleep deprivation promotes a state of generalized hyperalgesia: a surrogate pain model to study the relationship of insomnia and pain. Pain 2013 1.63
6 Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J Neurosci 1998 1.54
7 Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HCl. Eur J Pharmacol 1967 1.30
8 From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics. Pharmacogenet Genomics 2009 1.11
9 Involvement of the dorsal raphe but not median raphe nucleus in morphine-induced increases in serotonin release in the rat forebrain. Neuroscience 1995 1.03
10 Palonosetron (Aloxi): a second-generation 5-HT₃ receptor antagonist for chemotherapy-induced nausea and vomiting. Proc (Bayl Univ Med Cent) 2006 0.97
11 Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans. Addiction 2003 0.94
12 Opioid induced nausea and vomiting. Eur J Pharmacol 2013 0.92
13 Palonosetron: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesis. Expert Opin Pharmacother 2003 0.91
14 Sites of action of ondansetron to inhibit withdrawal from drugs of abuse. Pharmacol Biochem Behav 1990 0.90
15 Poor sleep quality is strongly associated with subsequent pain intensity in patients with acute low back pain. Arthritis Rheumatol 2014 0.90
16 Alteration in regulation of serotonin release in rat dorsal raphe nucleus after prolonged exposure to morphine. J Pharmacol Exp Ther 1998 0.89
17 Effects of ondansetron administration on opioid withdrawal syndrome observed in rats. Eur J Pharmacol 1997 0.88
18 Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes? J Med Toxicol 2014 0.81
19 5-HT3 receptor antagonists for the treatment of nausea/vomiting. Ann Palliat Med 2012 0.81
20 Precipitated opioid withdrawal across acute physical dependence induction methods. Pharmacol Biochem Behav 2004 0.81
21 Treatment of Nausea and Vomiting During Chemotherapy. US Oncol Hematol 2011 0.80
22 Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated rats. Psychopharmacology (Berl) 2003 0.80
23 Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist. Methods Find Exp Clin Pharmacol 1996 0.79
24 Brain and spinal cord 5-HT2 receptors of morphine-tolerant-dependent and -abstinent rats. Eur J Pharmacol 1989 0.79
25 Influence of the menstrual cycle on neuroendocrine and behavioral responses to an opiate agonist in humans: preliminary results. Psychoneuroendocrinology 1988 0.78
26 Tropisetron attenuates naloxone-induced place aversion in single-dose morphine-treated rats: role of alpha7 nicotinic receptors. Eur J Pharmacol 2009 0.77
27 Effects of alpha4beta2 and alpha7 nicotinic acetylcholine receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats. Eur J Pharmacol 2005 0.77
28 The possible role of brain histamine and H1 and H2 receptors in the development of morphine tolerance and physical dependence in mice. Agents Actions 1975 0.76
29 A call for cultural transformation of attitudes toward pain and its prevention and management. J Pain Palliat Care Pharmacother 2011 0.76
30 Hydroxyzine premedication--does it provide better anxiolysis than a placebo? S Afr Med J 1996 0.75
31 The effects of L-histidine and of specific histamine receptor agonists, on the expression of morphine tolerance and physical dependence in mice. Agents Actions 1976 0.75
32 The effects of chronic morphine treatment on histamine concentration and histidine decarboxylase activity in rat brain. Prog Neuropsychopharmacol 1978 0.75
Next 100